AP-1 Oligodeoxynucleotides Reduce Aortic Elastolysis in a Murine Model of Marfan Syndrome-Reference-Cited by-同舟云学术

AP-1 Oligodeoxynucleotides Reduce Aortic Elastolysis in a Murine Model of Marfan Syndrome

Published:2017-12 Issue: Volume:9 Page:69-79
ISSN:2162-2531
Container-title:Molecular Therapy - Nucleic Acids
language:en
Short-container-title:Molecular Therapy - Nucleic Acids

Author:

Arif Rawa,Zaradzki Marcin,Remes Anca,Seppelt Philipp,Kunze Reiner,Schröder Hannes,Schwill Simon,Ensminger Stephan M.,Robinson Peter N.,Karck Matthias,Müller Oliver J.,Hecker Markus,Wagner Andreas H.,Kallenbach Klaus

Funder

B. Braun Foundation

Baden-Württemberg

Publisher

Elsevier BV

Subject

Drug Discovery,Molecular Medicine

Reference52 articles.

1. Life expectancy and causes of death in the Marfan syndrome;Murdoch;N. Engl. J. Med.,1972

2. An aortic valve-sparing operation for patients with aortic incompetence and aneurysm of the ascending aorta;David;J. Thorac. Cardiovasc. Surg.,1992

3. Aortic valve-sparing operation in Marfan syndrome: what do we know after a decade?;Kallenbach;Ann. Thorac. Surg.,2007

4. Angiotensin II type 2 receptor signaling attenuates aortic aneurysm in mice through ERK antagonism;Habashi;Science,2011

5. Marfan Sartan: a randomized, double-blind, placebo-controlled trial;Milleron;Eur. Heart J.,2015

Cited by 17 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. An exploration of alternative therapeutic targets for aortic disease in Marfan syndrome;Drug Discovery Today;2024-07

2. The role of transcription factors in the pathogenesis and therapeutic targeting of vascular diseases;Frontiers in Cardiovascular Medicine;2024-04-30

3. Regnase-1 overexpression as a therapeutic approach of Marfan syndrome;Molecular Therapy - Methods & Clinical Development;2024-03

4. Oligonucleotides and mRNA Therapeutics;Pharmaceutical Biotechnology;2024

5. Short-term rapamycin treatment increases life span and attenuates aortic aneurysm in a murine model of Marfan-Syndrome;Biochemical Pharmacology;2022-11